Pacer Advisors Inc. Sells 464,507 Shares of USANA Health Sciences, Inc. (NYSE:USNA)

Key Points

• Pacer Advisors Inc. reduced its stake in USANA Health Sciences by 78.5%, selling 464,507 shares to now hold approximately 0.68% of the company.
• USANA's stock has seen a performance dip, trading at $30.29, with a recent earnings report showing EPS of $0.74, exceeding analyst expectations of $0.54.
• Several hedge funds have increased their positions in USANA, with Versant Capital Management boosting holdings by 542.5% in the first quarter.

Pacer Advisors Inc. lessened its holdings in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 78.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 127,494 shares of the company's stock after selling 464,507 shares during the quarter. Pacer Advisors Inc. owned 0.68% of USANA Health Sciences worth $3,439,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently added to or reduced their stakes in USNA. Dimensional Fund Advisors LP increased its holdings in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock valued at $27,751,000 after buying an additional 55,059 shares during the last quarter. Teacher Retirement System of Texas bought a new position in shares of USANA Health Sciences during the 1st quarter worth approximately $888,000. Jane Street Group LLC boosted its holdings in shares of USANA Health Sciences by 330.0% in the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company's stock valued at $1,435,000 after acquiring an additional 30,681 shares during the last quarter. Norges Bank purchased a new stake in shares of USANA Health Sciences in the 4th quarter valued at $953,000. Finally, American Century Companies Inc. lifted its stake in shares of USANA Health Sciences by 12.3% in the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company's stock valued at $8,391,000 after purchasing an additional 25,522 shares during the period. Hedge funds and other institutional investors own 54.25% of the company's stock.

Analysts Set New Price Targets

Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a report on Thursday, May 22nd.

USANA Health Sciences Stock Performance

USNA traded down $0.64 on Wednesday, reaching $29.62. 126,427 shares of the company's stock were exchanged, compared to its average volume of 184,583. The company has a market cap of $551.52 million, a price-to-earnings ratio of 16.46, a PEG ratio of 1.00 and a beta of 0.64. USANA Health Sciences, Inc. has a twelve month low of $23.10 and a twelve month high of $45.86. The company's 50 day moving average is $30.93 and its 200-day moving average is $30.01.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $0.74 EPS for the quarter, beating analysts' consensus estimates of $0.54 by $0.20. USANA Health Sciences had a return on equity of 9.48% and a net margin of 3.79%. The company had revenue of $235.85 million for the quarter, compared to analyst estimates of $225.20 million. Sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Buying and Selling

In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of the business's stock in a transaction dated Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO G Doug Iiekking sold 4,548 shares of the company's stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $29.61, for a total value of $134,666.28. The disclosure for this sale can be found here. Insiders sold a total of 12,013 shares of company stock worth $360,149 over the last three months. 0.63% of the stock is owned by company insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.